ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

Luchini, C.; Bibeau, F.; Ligtenberg, M.J.L.; Singh, N.; Nottegar, A.; Bosse, T.; ... ; Scarpa, A. (2019)

Article / Letter to editor

• microsatellite instability (MSI)
• tumour mutational burden (TMB)
• tumour mutational load (TML)
• next-generation sequencing (NGS)
• immunotherapy

• All authors: Luchini, C.; Bibeau, F.; Ligtenberg, M.J.L.; Singh, N.; Nottegar, A.; Bosse, T.; Miller, R.; Riaz, N.; Douillard, J.Y.; Andre, F.; Scarpa, A.
• Date: 2019-08-31
• Journal: Annals of Oncology
• Volume: 30
• Issue: 8
• Pages: 1232 - 1243
• DOI: doi:10.1093/annonc/mdz116